Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B London

Showing results (81-90 of 310) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group studyTara O Henderson, Smita Bhatia, Navin Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2012
Mechanisms of CHD5 Inactivation in neuroblastomasHiroshi Koyama, Tiangang Zhuang, Jennifer E Light, et al.
JAMA Oncology|September 10, 2020
Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group TrialsDanielle S Bitterman, Kira Bona, Fran Laurie, et al.
Pediatric Blood & Cancer|January 8, 2016
Newborn Screening for Sickle Cell Disease in Liberia: A Pilot StudyVenée N Tubman, Roseda Marshall, Wilhemina Jallah, et al.
Cancer|January 23, 1998
Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-upJ F Stastny, R E Remmers, W B London, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Pediatric Blood & Cancer|February 18, 2011
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupArlene Naranjo, Marguerite T Parisi, Barry L Shulkin, et al.
Cancer|September 9, 2017
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trialsWendy B London, Rochelle Bagatell, Brenda J Weigel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcomeQiwei Yang, Colleen M Kiernan, Yufeng Tian, et al.
Journal of Pediatric Surgery|March 13, 2003
Malignant retroperitoneal and abdominal germ cell tumors: an intergroup studyD Billmire, C Vinocur, F Rescorla, et al.
Pageof 31

Showing results (81-90 of 310) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group studyTara O Henderson, Smita Bhatia, Navin Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2012
Mechanisms of CHD5 Inactivation in neuroblastomasHiroshi Koyama, Tiangang Zhuang, Jennifer E Light, et al.
JAMA Oncology|September 10, 2020
Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group TrialsDanielle S Bitterman, Kira Bona, Fran Laurie, et al.
Pediatric Blood & Cancer|January 8, 2016
Newborn Screening for Sickle Cell Disease in Liberia: A Pilot StudyVenée N Tubman, Roseda Marshall, Wilhemina Jallah, et al.
Cancer|January 23, 1998
Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-upJ F Stastny, R E Remmers, W B London, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Pediatric Blood & Cancer|February 18, 2011
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupArlene Naranjo, Marguerite T Parisi, Barry L Shulkin, et al.
Cancer|September 9, 2017
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trialsWendy B London, Rochelle Bagatell, Brenda J Weigel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcomeQiwei Yang, Colleen M Kiernan, Yufeng Tian, et al.
Journal of Pediatric Surgery|March 13, 2003
Malignant retroperitoneal and abdominal germ cell tumors: an intergroup studyD Billmire, C Vinocur, F Rescorla, et al.
Pageof 31